NCT01424475View on ClinicalTrials.gov

LRRK2 Mutation and Parkinson's Disease

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

August 11, 2011

Primary Completion Date

January 12, 2015

Study Completion Date

January 12, 2015

Conditions
Parkinson Disease
Interventions
GENETIC

Healthy

Healthy Volunteers

GENETIC

PKD Patients

PKS Patients

Trial Locations (1)

CB2 2GG

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY